Overall market sentiment has been high on Spectrum Pharmaceuticals, Inc. (SPPI) stock lately. SPPI receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With SPPI Stock Today?
Spectrum Pharmaceuticals, Inc. (SPPI) stock is trading at $3.91 as of 10:49 AM on Monday, Feb 8, an increase of $0.10, or 2.62% from the previous closing price of $3.81. The stock has traded between $3.83 and $3.98 so far today. Volume today is less active than usual. So far 1,039,928 shares have traded compared to average volume of 2,197,411 shares.
To see the top 5 stocks in the Biotechnology industry click here.
More About Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. As an oncology products manufacturer, it develops drugs to combat various kinds of tumors. The SPI-2012 is being developed for chemotherapy-induced neutropenia in patients with breast cancer, and EOQUIN addresses immediate intravesical instillation and post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer.
Click Here to get the full Stock Score Report on Spectrum Pharmaceuticals, Inc. (SPPI) Stock.
